Department of Psychiatry
Penn Behavioral Health

Delaware Valley Node National Drug Abuse Treatment Clinical Trials Network

subpage feature

Completed Studies

 

CTN-0002 - Buprenorphine/Naloxone versus Clonidine for Outpatient Opiate Detoxification


CTN-0004
- MET to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse


CTN-0006
- Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics


CTN-0007
- Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics


CTN-0008
- Assessment of the National Drug Abuse Clinical Trials Network: A Baseline for Investigating Diffusion of Innovation

Sites: All


CTN-0010
- Buprenorphine/Naloxone-Facilitated Rehabilitation for Opioid Dependent Adolescent/Young Adults


CTN-0012
- Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infections, and Sexually Transmitted Infections in Substance Abuse Treatment Programs



CTN-0018
- Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment



CTN-0019
- Reducing HIV/STD Risk Behaviors: A Research Study for Women in Drug Abuse Treatment



CTN-0027
- Starting Treatment with Agonist Replacement Therapies (START)



CTN-0027-A-1
- START Pharmacogenetics: Exploratory Genetic Studies in Starting Treatment with Agonist Replacement Therapies



CTN-0027-A-2
- Retention of Suboxone Patients in START: Perspectives of Providers and Patients



CTN-0028
- Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents (with Substance Use Disorder)


CTN-0037 - Stimulant Reduction Intervention using Dosed Exercise(STRIDE)


CTN-0052 - Buspirone for Relapse-Prevention in Adults with Cocaine Dependence  (BRAC)


For additional information on any of the protocols listed above, please visit the NIDA Dissemination Library - http://ctndisseminationlibrary.org/